Detalhe da pesquisa
1.
Characterization of Selective and Potent JAK1 Inhibitors Intended for the Inhaled Treatment of Asthma.
Drug Des Devel Ther
; 16: 2901-2917, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36068788
2.
AZD0284, a Potent, Selective, and Orally Bioavailable Inverse Agonist of Retinoic Acid Receptor-Related Orphan Receptor C2.
J Med Chem
; 64(18): 13807-13829, 2021 09 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-34464130
3.
Potent and Orally Bioavailable Inverse Agonists of RORγt Resulting from Structure-Based Design.
J Med Chem
; 61(17): 7796-7813, 2018 09 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-30095900
4.
Molecular cloning, mutations and effects of NK1 receptor antagonists reveal the human-like pharmacology of gerbil NK1 receptors.
Biochem Pharmacol
; 73(2): 259-69, 2007 Jan 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-17097619
5.
Senktide-induced gerbil foot tapping behaviour is blocked by selective tachykinin NK1 and NK3 receptor antagonists.
Eur J Pharmacol
; 577(1-3): 78-86, 2007 Dec 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-17920583
6.
Benzoxazepines Achieve Potent Suppression of IL-17 Release in Human T-Helper 17 (TH 17) Cells through an Induced-Fit Binding Mode to the Nuclear Receptor RORγ.
ChemMedChem
; 11(2): 207-16, 2016 Jan 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-26553345
7.
Characterization of species-related differences in the pharmacology of tachykinin NK receptors 1, 2 and 3.
Biochem Pharmacol
; 77(9): 1522-30, 2009 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-19426690